No significant weaknesses identified
| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| AGOAssured Guaranty Ltd. | 3.95B | 85.56 | 12.45 | -19.8% | 42.14% | 7.01% | 1.19% | 0.31 |
| AMBCAmbac Financial Group, Inc. | 276.45M | 6.31 | 4.44 | 89.06% | -7.87% | -67.99% | 0.28% | 0.13 |
| MBIMBIA Inc. | 354.47M | 7.02 | -0.75 | 5% | -195.51% |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.96B | 1.38B | 1.65B | 987M | 924M | 1.08B | 698M | 684M | 1.01B | 814M |
| Revenue Growth % | 0.12% | -0.29% | 0.2% | -0.4% | -0.06% | 0.17% | -0.36% | -0.02% | 0.48% | -0.2% |
| Medical Costs & Claims | 444M | 313M | 407M | 80M | 111M | 219M | -206M | 30M | 175M | -6M |
| Medical Cost Ratio % | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 1.51B | 1.07B | 1.24B | 907M | 813M | 865M | 904M | 654M | 840M | 820M |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | -0.05% | -0.29% | 0.17% | -0.27% | -0.1% | 0.06% | 0.05% | -0.28% | 0.28% | -0.02% |
| Operating Expenses | 80M | 50M | 253M | 327M | 349M | 452M | 427M | 506M | 172M | 332M |
| OpEx / Revenue % | - | - | - | - | - | - | - | - | - | - |
| Depreciation & Amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Combined Ratio % | - | - | - | - | - | - | - | - | - | - |
| Operating Income | 1.43B | 1.02B | 991M | 580M | 464M | 413M | 477M | 148M | 668M | 488M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | -0.07% | -0.29% | -0.03% | -0.41% | -0.2% | -0.11% | 0.15% | -0.69% | 3.51% | -0.27% |
| EBITDA | 1.53B | 1.12B | 1.09B | 674M | 553M | 498M | 564M | 229M | 758M | 579M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - |
| Interest Expense | 101M | 102M | 97M | 94M | 89M | 85M | 87M | 81M | 90M | 91M |
| Non-Operating Income | -101M | -102M | -97M | -94M | -89M | -85M | -87M | -81M | -90M | -91M |
| Pretax Income | 1.43B | 1.02B | 991M | 580M | 464M | 413M | 477M | 148M | 668M | 488M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 375M | 136M | 261M | 59M | 63M | 45M | 58M | 11M | -93M | 96M |
| Effective Tax Rate % | - | - | - | - | - | - | - | - | - | - |
| Net Income | 1.06B | 881M | 730M | 521M | 402M | 362M | 389M | 124M | 739M | 376M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | -0.03% | -0.17% | -0.17% | -0.29% | -0.23% | -0.1% | 0.07% | -0.68% | 4.96% | -0.49% |
| EPS (Diluted) | 7.08 | 6.56 | 5.96 | 4.68 | 4.00 | 4.19 | 5.24 | 1.92 | 12.30 | 6.87 |
| EPS Growth % | 0.13% | -0.07% | -0.09% | -0.21% | -0.15% | 0.05% | 0.25% | -0.63% | 5.41% | -0.44% |
| EPS (Basic) | 7.12 | 6.61 | 6.05 | 4.74 | 4.04 | 4.22 | 5.29 | 1.96 | 12.55 | 7.01 |
| Diluted Shares Outstanding | 149M | 134.1M | 122.3M | 111.3M | 100.2M | 86.2M | 74.3M | 63.9M | 59.6M | 54.3M |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | 14.54B | 14.15B | 14.43B | 13.6B | 14.33B | 15.33B | 18.21B | 16.84B | 12.54B | 11.9B |
| Asset Growth % | -0.03% | -0.03% | 0.02% | -0.06% | 0.05% | 0.07% | 0.19% | -0.07% | -0.26% | -0.05% |
| Total Investment Assets | 12.53B | 11.87B | 12.1B | 11.44B | 20.69B | 10.13B | 19.11B | 16.58B | 9.44B | 8.81B |
| Long-Term Investments | 12.28B | 11.7B | 12B | 11.39B | 10.56B | 9.92B | 9.69B | 8.65B | 8.61B | 7.88B |
| Short-Term Investments | 11.02B | 10.82B | 11.3B | 10.82B | 10.12B | 9.62B | 9.43B | 7.93B | 7.97B | 2.34B |
| Total Current Assets | 11.53B | 10.94B | 11.75B | 12.32B | 12.32B | 0 | 11.72B | 9.59B | 0 | 0 |
| Cash & Equivalents | 166M | 118M | 144M | 104M | 169M | 162M | 120M | 107M | 97M | 121M |
| Receivables | 0 | 0 | 0 | 0 | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Other Current Assets | 0 | 0 | 0 | 0 | 4.35B | -12.15B | 3.6B | 2.92B | -9.83B | -4.41B |
| Goodwill & Intangibles | 114M | 106M | 101M | 129M | 216M | 203M | 175M | 163M | 6M | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 117M | 117M | 117M | 117M | 0 | 0 |
| Intangible Assets | 114M | 106M | 101M | 129M | 99M | 86M | 58M | 46M | 6M | 0 |
| PP&E (Net) | -114M | -106M | -101M | 10.96B | 572M | 1.91B | 5.27B | 5.49B | 366M | 101M |
| Other Assets | -12.28B | -11.7B | -12B | -11.39B | -254M | -12.04B | -195M | -114M | -8.99B | -7.99B |
| Total Liabilities | 8.48B | 7.65B | 7.59B | 7.05B | 7.67B | 8.63B | 11.71B | 11.55B | 6.77B | 6.35B |
| Total Debt | 1.3B | 1.31B | 1.29B | 1.23B | 1.24B | 1.22B | 1.67B | 1.68B | 1.69B | 1.7B |
| Net Debt | 1.13B | 1.19B | 1.15B | 1.13B | 1.07B | 1.06B | 1.55B | 1.57B | 1.6B | 1.58B |
| Long-Term Debt | 1.3B | 1.31B | 1.29B | 1.23B | 1.24B | 1.08B | 1.67B | 1.68B | 1.69B | 1.7B |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 145M | 23M | 23M | 0 | 0 |
| Total Current Liabilities | 51M | 64M | 61M | 1.18B | 1.08B | 0 | 928M | 297M | 0 | 0 |
| Accounts Payable | 51M | 64M | 61M | 0 | 30M | 0 | 16M | 1M | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 43M | 0 | 0 | 0 |
| Other Current Liabilities | -51M | -64M | -61M | 0 | 1.05B | -145M | 276M | 161M | 0 | 0 |
| Deferred Taxes | 1000K | 1000K | 1000K | 1000K | 1000K | 0 | 1000K | 0 | 0 | 0 |
| Other Liabilities | 0 | 0 | 0 | 5.82B | 6.44B | -1.08B | -1.67B | 9.88B | -1.69B | -1.7B |
| Total Equity | 6.06B | 6.5B | 6.84B | 6.55B | 6.65B | 6.71B | 6.5B | 5.29B | 5.76B | 5.55B |
| Equity Growth % | 0.05% | 0.07% | 0.05% | -0.04% | 0.01% | 0.01% | -0.03% | -0.19% | 0.09% | -0.04% |
| Shareholders Equity | 6.06B | 6.5B | 6.84B | 6.55B | 6.64B | 6.64B | 6.29B | 5.06B | 5.71B | 5.5B |
| Minority Interest | 0 | 0 | 0 | 0 | 13M | 62M | 208M | 228M | 52M | 58M |
| Retained Earnings | 4.48B | 5.29B | 5.89B | 6.37B | 6.29B | 6.14B | 5.99B | 5.58B | 6.07B | 5.88B |
| Common Stock | 1M | 1M | 1M | 1M | 1M | 1M | 1M | 1M | 1M | 1M |
| Accumulated OCI | 237M | 149M | 372M | 93M | 342M | 498M | 300M | -515M | -359M | -385M |
| Return on Equity (ROE) | 0.18% | 0.14% | 0.11% | 0.08% | 0.06% | 0.05% | 0.06% | 0.02% | 0.13% | 0.07% |
| Return on Assets (ROA) | 0.07% | 0.06% | 0.05% | 0.04% | 0.03% | 0.02% | 0.02% | 0.01% | 0.05% | 0.03% |
| Equity / Assets | - | - | - | - | - | - | - | - | - | - |
| Debt / Equity | 0.21x | 0.20x | 0.19x | 0.19x | 0.19x | 0.18x | 0.26x | 0.32x | 0.29x | 0.31x |
| Book Value per Share | 40.69 | 48.50 | 55.92 | 58.89 | 66.39 | 77.78 | 87.48 | 82.82 | 96.73 | 102.27 |
| Tangible BV per Share | - | - | - | - | - | - | - | - | - | - |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -52M | -141M | 433M | 462M | -509M | -853M | -1.94B | -2.48B | 461M | 47M |
| Operating CF Growth % | -1.09% | -1.71% | 4.07% | 0.07% | -2.1% | -0.68% | -1.27% | -0.28% | 1.19% | -0.9% |
| Operating CF / Revenue % | - | - | - | - | - | - | - | - | - | - |
| Net Income | 1.06B | 881M | 730M | 521M | 137M | 368M | 419M | 137M | 761M | 376M |
| Depreciation & Amortization | -25M | -34M | -46M | -31M | -35M | 13M | 12M | 11M | 0 | 0 |
| Stock-Based Compensation | 10M | 13M | 16M | 19M | 21M | 25M | 27M | 39M | 0 | 0 |
| Deferred Taxes | 300M | 19M | 250M | 74M | 65M | 58M | -38M | -3M | -156M | -4M |
| Other Non-Cash Items | 31M | -27M | -26M | 32M | 3M | -975M | -2.36B | -1.34B | -8M | -215M |
| Working Capital Changes | -471M | -720M | -284M | -165M | -700M | -342M | 2M | -1.32B | -136M | -110M |
| Cash from Investing | 994M | 1.08B | 345M | 297M | 1.17B | 788M | 23M | 1.74B | 286M | 780M |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 25M | 0 | 0 |
| Acquisitions | -800M | -435M | 95M | 0 | -233M | -19M | -79M | -25M | -198M | 0 |
| Purchase of Investments | -2.58B | -1.65B | -2.55B | -2.21B | -1.73B | -1.47B | -1.65B | -459M | -1.43B | -1.35B |
| Sale/Maturity of Investments | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 0 |
| Other Investing | 469M | 620M | 206M | 133M | 187M | 84M | 56M | 81M | 172M | 2.13B |
| Cash from Financing | -847M | -978M | -766M | -795M | -584M | 183M | 1.96B | 612M | -670M | -983M |
| Dividends Paid | -72M | -69M | -70M | -71M | -74M | -69M | -66M | -64M | -67M | -68M |
| Share Repurchases | -562M | -308M | -501M | -500M | -500M | -446M | -496M | -500M | -199M | -502M |
| Stock Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debt Issuance (Net) | -1000K | -1000K | -1000K | -1000K | 1000K | 1000K | 1000K | 1000K | -1000K | -1000K |
| Other Financing | -209M | 12M | -165M | -123M | -182M | -42M | 0 | -57M | -248M | -38M |
| Net Change in Cash | 91M | -48M | 17M | -40M | 79M | 115M | 44M | -135M | 79M | -158M |
| Exchange Rate Effect | -1000K | -1000K | 1000K | -1000K | 1000K | -1000K | -1000K | -1000K | 1000K | -1000K |
| Cash at Beginning | 75M | 166M | 127M | 144M | 104M | 183M | 298M | 342M | 207M | 286M |
| Cash at End | 166M | 118M | 144M | 104M | 183M | 298M | 342M | 207M | 286M | 128M |
| Free Cash Flow | -52M | -141M | 433M | 462M | -509M | -853M | -1.94B | -2.45B | 461M | 47M |
| FCF Growth % | -1.09% | -1.71% | 4.07% | 0.07% | -2.1% | -0.68% | -1.27% | -0.27% | 1.19% | -0.9% |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - |
| FCF per Share | -0.35 | -1.05 | 3.54 | 4.15 | -5.08 | -9.9 | -26.07 | -38.4 | 7.73 | 0.87 |
| Metric | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Combined Ratio | 26.8% | 26.3% | 39.98% | 41.24% | 49.78% | 61.9% | 31.66% | 78.36% | 34.19% | 40.05% |
| Medical Cost Ratio | 22.71% | 22.68% | 24.65% | 8.11% | 12.01% | 20.2% | -29.51% | 4.39% | 17.24% | -0.74% |
| Return on Equity (ROE) | 17.87% | 14.02% | 10.94% | 7.78% | 6.09% | 5.42% | 5.89% | 2.1% | 13.37% | 6.64% |
| Return on Assets (ROA) | 7.17% | 6.14% | 5.11% | 3.72% | 2.88% | 2.44% | 2.32% | 0.71% | 5.03% | 3.08% |
| Equity / Assets | 41.69% | 45.96% | 47.38% | 48.19% | 46.43% | 43.73% | 35.7% | 31.42% | 45.98% | 46.66% |
| Book Value / Share | 40.69 | 48.5 | 55.92 | 58.89 | 66.39 | 77.78 | 87.48 | 82.82 | 96.73 | 102.27 |
| Debt / Equity | 0.21x | 0.20x | 0.19x | 0.19x | 0.19x | 0.18x | 0.26x | 0.32x | 0.29x | 0.31x |
| Revenue Growth | 12.42% | -29.41% | 19.64% | -40.22% | -6.38% | 17.32% | -35.61% | -2.01% | 48.39% | -19.8% |
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Insurance | - | - | - | - | - | - | 733M | 757M | 855M | 821M |
| Insurance Growth | - | - | - | - | - | - | - | 3.27% | 12.95% | -3.98% |
| Asset Management | - | - | - | - | - | - | 83M | 112M | 76M | 10M |
| Asset Management Growth | - | - | - | - | - | - | - | 34.94% | -32.14% | -86.84% |
| Asset Management Fees, CLO's | - | - | - | - | 18M | 54M | - | - | - | - |
| Asset Management Fees, CLO's Growth | - | - | - | - | - | 200.00% | - | - | - | - |
| Collateralized Loan Obligations, Before Rebates | - | - | - | - | 11M | 40M | - | - | - | - |
| Collateralized Loan Obligations, Before Rebates Growth | - | - | - | - | - | 263.64% | - | - | - | - |
| Reimbursable Fund Expense | - | - | - | - | - | 35M | - | - | - | - |
| Reimbursable Fund Expense Growth | - | - | - | - | - | - | - | - | - | - |
| Wind-down Funds | - | - | - | - | 13M | 25M | - | - | - | - |
| Wind-down Funds Growth | - | - | - | - | - | 92.31% | - | - | - | - |
| Collateralized Loan Obligation Service | - | - | - | - | 3M | 21M | - | - | - | - |
| Collateralized Loan Obligation Service Growth | - | - | - | - | - | 600.00% | - | - | - | - |
| Opportunity Funds | - | - | - | - | 2M | 8M | - | - | - | - |
| Opportunity Funds Growth | - | - | - | - | - | 300.00% | - | - | - | - |
| Performance Allocation Fees | - | - | - | - | 4M | - | - | - | - | - |
| Performance Allocation Fees Growth | - | - | - | - | - | - | - | - | - | - |
| Financial Guarantee Insurance Product Line | 3.77B | 3.34B | 3.41B | 3.51B | - | - | - | - | - | - |
| Financial Guarantee Insurance Product Line Growth | - | -11.35% | 1.94% | 3.08% | - | - | - | - | - | - |
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| UNITED STATES | - | - | - | - | 761M | 788M | 762M | 727M | 1.06B | 685M |
| UNITED STATES Growth | - | - | - | - | - | 3.55% | -3.30% | -4.59% | 46.35% | -35.62% |
| BERMUDA | - | - | - | - | 161M | 155M | 153M | 129M | 166M | 168M |
| BERMUDA Growth | - | - | - | - | - | -3.73% | -1.29% | -15.69% | 28.68% | 1.20% |
| UNITED KINGDOM | - | - | - | - | - | - | 42M | 32M | 36M | 32M |
| UNITED KINGDOM Growth | - | - | - | - | - | - | - | -23.81% | 12.50% | -11.11% |
| Other Countries | - | - | - | - | - | 8M | 3M | -1M | 1M | 1M |
| Other Countries Growth | - | - | - | - | - | - | -62.50% | -133.33% | 200.00% | 0.00% |
Assured Guaranty Ltd. (AGO) has a price-to-earnings (P/E) ratio of 12.5x. This may indicate the stock is undervalued or faces growth challenges.
Assured Guaranty Ltd. (AGO) saw revenue decline by 19.8% over the past year.
Yes, Assured Guaranty Ltd. (AGO) is profitable, generating $402.0M in net income for fiscal year 2024 (46.2% net margin).
Yes, Assured Guaranty Ltd. (AGO) pays a dividend with a yield of 1.46%. This makes it attractive for income-focused investors.
Assured Guaranty Ltd. (AGO) has a return on equity (ROE) of 6.6%. This is below average, suggesting room for improvement.
Assured Guaranty Ltd. (AGO) has a combined ratio of 40.0%. A ratio below 100% indicates underwriting profitability.